Abstract
INTRODUCTION:There are symptoms present in multiple sclerosis (MS), they are not directly related with the demyelinating nature of relapses, they affect and deteriorate patients' quality of life and they have not been adequately characterized in the colombian population.
OBJECTIVE:To describe the clinical, sociodemographic and symptomatic characteristics of patients with MS in the Neurology Department of the Hospital San José de Bogotá.
MATERIALS AND METHODS:A case series study. Consecutive patients with a diagnosis of MS according to Mc Donald 2010 criteria who were attended at the Hospital de San José between August 2015 and March 2017. Sociodemographic, clinical and symptom variables were evaluated with fatigue intensity scale, Hamilton depression scale, disability scale (EDSS), and questionnaire of sexuality and intimacy in MS. Data were analyzed in STATA 13.
RESULTS:65 patients were included. 72% female. Symptoms present: fatigue (75 %), headache (43 %), urinary dysfunction (38 %), depression (39 %), sleep disorders (32 %), anorectal dysfunction (27 %) and sexual dysfunction (20 %). In patients with depression, 64 % have sleep disorders associated. 50 % of patients with fatigue and depression had 9 years or less of disease progression and 11 years or less of those with urinary dysfunction.
DISCUSSION AND CONCLUSIONS:Fatigue and depression are likely to be associated with increased of presentation of sleep disorders and sexual dysfunction, they are evidenced in patients with a longer evolution of the disease.
References
Carretero Ares JL, Bowakim Dib W, Acebes Rey JM. Actualización: esclerosis múltiple. Medifam. 2001;11:30-43.
Ebers GC. Environmental factors and multiple sclerosis. The Lancet Neurology. 2008;7(3):268-77.
Huang WJ Chen WW, Zhang X. Multiple sclerosis: Pathology, diagnosis and treatments. Exp Ther Med. 2017;13(6):3163-6.
Ontaneda D, Thompson AJ, Fox RJ, Cohen JA. Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function. Lancet. 2017;389(10076):1357-66.
Sá MJ. Physiopathology of symptoms and signs in multiple sclerosis. Arq Neuropsiquiatr. 2012;70(9):733-40.
Covo P. Introducción a la historia de la esclerosis múltiple. Acta Neurológica Colombiana. 2015;31:119-24.
Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BY, et al. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Neurology. 2014;83(11):1022-4.
Toro J, Cárdenas S, Fernando Martínez C, Urrutia J, Díaz C. Multiple sclerosis in Colombia and other Latin American Countries. Multiple Sclerosis and Related Disorders. 2013;2(2):80-9.
Jiménez-Pérez CE, Zarco-Montero LA, Castañeda-Cardona C, Otálora Esteban M, Martínez A, Rosselli D. Estado actual de la esclerosis múltiple en Colombia. Acta Neurol Colomb. 2015;31(4):385-90.
Sánchez JL, Aguirre C, Arcos-Burgos OM, Jiménez I, Jiménez M, León F, et al. [Prevalence of multiple sclerosis in Colombia]. Rev Neurol. 2000;31(12):1101-3.
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302.
Brownlee WJ, Hardy TA, Fazekas F, Miller DH. Diagnosis of multiple sclerosis: progress and challenges. Lancet. 2017;389(10076):1336-46.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444-52.
Motl RW, Learmonth YC. Neurological disability and its association with walking impairment in multiple sclerosis: brief review. Neurodegener Dis Manag. 2014;4(6):491-500.
Rae-Grant AD. Unusual symptoms and syndromes in multiple sclerosis. Continuum (Minneap Minn). 2013;19(4 Multiple Sclerosis):992-1006.
Khan F, Amatya B, Galea M. Management of fatigue in persons with multiple sclerosis. Front Neurol. 2014;5:177.
Terlizzi R, Merli E, Buccellato E, Giannini G, Favoni Y, Pierangeli G, et al. P037. Headache in multiple sclerosis: prevalence and clinical features in a case control-study. J Headache Pain. 2015;16(Suppl 1):A83.
Putzki N, Pfriem A, Limmroth Y, Yaldizli O, Tettenborn B, Diener HC, et al. Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. Eur J Neurol. 2009;16(2):262-7.
Marrie RA, Reingold S, Cohen J, Stuve O, Trojano M, Sorensen PS, et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review. Mult Scler. 2015.
Strober LB. Fatigue in multiple sclerosis: a look at the role of poor sleep. Front Neurol. 2015;6:21.
Dillon BE, Lemack GE. Urodynamics in the evaluation of the patient with multiple sclerosis: when are they helpful and how do we use them? Urol Clin North Am. 2014;41(3):439-44, ix.
Munteis E, Andreu M, Téllez MJ, Mon D, Ois A, Roquer J. Anorectal dysfunction in multiple sclerosis. Mult Scler. 2006;12(2):215-8.
Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol. 1988;45(4):435-7.
Bulbena A BG, Fernández de Larrinoa P. Medición Clínica en Psiquiatría y Psicología. Madrid: Masson SA; 2000.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
Ramos-Brieva J, Cordero Villafafila A. Validación de la versión castellana de la escala de Hamilton para la depresión. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1986;14:324-34.
Sanders AS, Foley, F. W, LaRocca, N. G., Zemon, Y. The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 (MSISQ-19). Sexyality and Disability. 2000;18(Issue 1):3-26. Available from: http://eds.b.ebscohost.com.ezproxy.unal.edu.co/eds/detail/detail?vid=2&sid=cecfa041-4655-44f8-a8b1-f9a6aca3d764@sessionmgr110&hid=121&bdata=Jmxhbmc9 ZXMmc2l0ZT1lZHMtbGl2ZQ==#AN=11303668&db=a9h.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808.
Cores EY, Yanotti S, Burin DI, Politis DG, Villa A. [Factors associated to the work situation of patients with multiple sclerosis]. Rev Neurol. 2014;58(4):175-83.
Pearson JF, Alla S, Clarke G, Mason DF, Anderson T, Richardson A, et al. Multiple Sclerosis impact on employment and income in New Zealand. Acta Neurol Scand. 2016.
Cadden M, Arnett P. Factors Associated with Employment Status in Individuals with Multiple Sclerosis. Int J MS Care. 2015;17(6):284-91.
Marrie RA, Cutter GR, Tyry T, Cofield SS, Fox R, Salter A. Upper limb impairment is associated with use of assistive devices and unemployment in multiple sclerosis. Mult Scler Relat Disord. 2017;13:87-92.
Pfleger CC, Flachs EM, Koch-Henriksen N. Social consequences of multiple sclerosis. Part 2. Divorce and separation: a historical prospective cohort study. Mult Scler. 2010;16(7):878-82.
Marrie RA, Reider N, Cohen J, Trojano M, Sorensen PS, Cutter G, et al. A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis. Mult Scler. 2014.
Gasparini S, Ferlazzo E, Ascoli M, Sueri C, Cianci Y, Russo C, et al. Risk factors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis. Neurol Sci. 2017;38(3):399-406.
Fiest KM, Fisk JD, Patten SB, Tremlett H, Wolfson C, Warren S, et al. Fatigue and Comorbidities in Multiple Sclerosis. Int J MS Care. 2016;18(2):96-104.
Pokryszko-Dragan A, BilMska M, Gruszka E, Biel L, Kamiáska K, Konieczna K. Sleep disturbances in patients with multiple sclerosis. Neurol Sci. 2013;34(8):1291-6.
Nagaraj K, Taly AB, Gupta A, Prasad C, Christopher R. Depression and sleep disturbances in patients with multiple sclerosis and correlation with associated fatigue. J Neurosci Rural Pract. 2013;4(4):387-91.
Lunde HM, Bjorvatn B, Myhr KM, B0 L. Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review. Acta Neurol Scand Suppl. 2013(196):24-30.
Alsaadi T, El Hammasi K, Shahrour TM, Shakra M, Turkawi L, Mudhafar A, et al. Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study. Mult Scler Int. 2015;2015:487159.
Boeschoten RE, Braamse AM, Beekman AT, Cuijpers P, van Oppen P, Dekker J, et al. Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis. J Neurol Sci. 2017;372:331-41.
Mõhrke J, Kropp P, Zettl UK. Headaches in multiple sclerosis patients might imply an inflammatorial process. PLoS One. 2013;8(8):e69570.
Patti F, Nicoletti A, Pappalardo A, Castiglione A, Lo Fermo S, Messina S, et al. Frequency and severity of headache is worsened by Interferon-? therapy in patients with multiple sclerosis. Acta Neurol Scand. 2012;125(2):91-5.
La Mantia L. Headache and multiple sclerosis: clinical and therapeutic correlations. Neurol Sci. 2009;30 Suppl 1:S23-6.
Sadiq A, Brucker BM. Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients. Curr Urol Rep. 2015;16(7):44.
Prévinaire JG, Lecourt G, Soler JM, Denys P. Sexual disorders in men with multiple sclerosis: evaluation and management. Ann Phys Rehabil Med. 2014;57(5):329-36.
Zamani M, Tavoli A, Yazd Khasti B, Sedighimornani N, Zafar M. Sexual Therapy for Women with Multiple Sclerosis and Its Impact on Quality of Life. Iran J Psychiatry. 2017;12(1):58-65.
Celik DB, Poyraz E, Bingõl A, Idiman E, Ozakbaj S, Kaya D. Sexual dysfunction in multiple sclerosis: gender differences. J Neurol Sci. 2013;324(1-2):17-20.
Nusrat S, Gulick E, Levinthal D, Bielefeldt K. Anorectal dysfunction in multiple sclerosis: a systematic review ISRN Neurol. 2012;2012:376023.W
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.